Caution Regarding Assessment of Toxic Effects and Survival in Treatment De-escalation With Radiotherapy vs Transoral Surgery for Human Papillomavirus-Associated Oropharyngeal Cancer.
作者信息
Paleri Vinidh, Simon Christian, Gorphe Philippe
机构信息
Head and Neck Unit, The Royal Marsden Hospital, London, United Kingdom.
Department of Otolaryngology-Head and Neck Surgery, Lausanne University Hospital, Lausanne, Switzerland.
出版信息
JAMA Oncol. 2022 Oct 1;8(10):1512-1513. doi: 10.1001/jamaoncol.2022.3461.
PMID:35980619
Abstract
摘要
相似文献
1
Caution Regarding Assessment of Toxic Effects and Survival in Treatment De-escalation With Radiotherapy vs Transoral Surgery for Human Papillomavirus-Associated Oropharyngeal Cancer.
JAMA Oncol. 2022 Oct 1;8(10):1512-1513. doi: 10.1001/jamaoncol.2022.3461.
2
Caution Regarding Assessment of Toxic Effects and Survival in Treatment De-escalation With Radiotherapy vs Transoral Surgery for Human Papillomavirus-Associated Oropharyngeal Cancer.
JAMA Oncol. 2022 Oct 1;8(10):1513. doi: 10.1001/jamaoncol.2022.3464.
3
Caution Regarding Assessment of Toxic Effects and Survival in Treatment De-escalation With Radiotherapy vs Transoral Surgery for Human Papillomavirus-Associated Oropharyngeal Cancer.
JAMA Oncol. 2022 Oct 1;8(10):1511-1512. doi: 10.1001/jamaoncol.2022.3458.
4
Caution Regarding Assessment of Toxic Effects and Survival in Treatment De-escalation With Radiotherapy vs Transoral Surgery for Human Papillomavirus-Associated Oropharyngeal Cancer-Reply.
JAMA Oncol. 2022 Oct 1;8(10):1513-1514. doi: 10.1001/jamaoncol.2022.3467.
5
Transoral Surgery and Deintensified Adjuvant Therapy: Another Step in Determining Its Role in the Management of Human Papillomavirus Oropharyngeal Cancer.
J Clin Oncol. 2022 Jan 10;40(2):114-117. doi: 10.1200/JCO.21.02364. Epub 2021 Nov 12.
6
A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Cancer. 2021 Dec 1;127(23):4330-4338. doi: 10.1002/cncr.33851. Epub 2021 Aug 11.
7
De-Escalation Strategies for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma-Where Are We Now?
Curr Oncol. 2022 May 18;29(5):3668-3697. doi: 10.3390/curroncol29050295.
8
Long-Term Toxic Effects, Swallow Function, and Quality of Life on MC1273: A Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in Human Papillomavirus-Positive Oropharyngeal Cancer.
Int J Radiat Oncol Biol Phys. 2022 Oct 1;114(2):256-265. doi: 10.1016/j.ijrobp.2022.05.047. Epub 2022 Jun 5.
9
[De-escalation of adjuvant radiotherapy after transoral surgery of HPV-associated oropharyngeal cancer: results of the E3311 trial].
Strahlenther Onkol. 2022 Apr;198(4):400-403. doi: 10.1007/s00066-022-01907-4. Epub 2022 Feb 8.
10
Therapeutic strategies: Surgery for human papillomavirus-associated oropharyngeal carcinoma.
J Surg Oncol. 2021 Nov;124(6):935-944. doi: 10.1002/jso.26695. Epub 2021 Sep 30.
Zotero 插件